The molecular diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $27.23 billion in 2025 to $30.33 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to growth in infectious disease testing, expansion of genetic screening programs, rising use of molecular diagnostics in oncology, improvements in sequencing accuracy, increased clinical awareness of molecular testing.
The molecular diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising investments in genomic diagnostics, expansion of decentralized molecular testing, growing adoption of automated sample processing, increasing focus on early-stage disease detection. Major trends in the forecast period include increasing adoption of pcr-based testing platforms, rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, expansion of companion diagnostics applications, enhanced focus on early and personalized diagnosis.
The increasing incidence of infectious diseases is expected to drive the growth of the molecular diagnostic devices and equipment market in the future. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals or from animals to humans. Factors contributing to the rise in infectious diseases include antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic devices and equipment are critical tools for the detection and management of these diseases. For example, in March 2023, the Office for National Statistics, a UK government department, reported that during the week ending March 17, 2023, the UK recorded 619 deaths related to COVID-19, an increase from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, a slight decrease from 4.6% the week before. Thus, the rising incidence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.
Major companies in the molecular diagnostics devices and equipment market are innovating by developing products such as high-throughput sample-to-result instruments for molecular diagnostics. ELITechGroup, for instance, launched a high-throughput sample-to-result instrument in April 2023, based on its proven extraction and assay technology. The instrument allows continuous loading of samples and reagents with real random-access capability, providing users with the flexibility to run different PCR reagents, protocols, and sample matrices in parallel.
In February 2023, Sherlock Biosciences, a US-based synthetic biology firm, acquired Sense Bio-detection for an undisclosed sum. With this acquisition, Sherlock intends to enhance its CRISPR-based molecular diagnostics capabilities by incorporating Sense Bio-detection’s Veros instrument-free rapid test platform and manufacturing expertise. Sense Bio-detection is a UK-based molecular diagnostics company offering single-use molecular testing devices.
Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular diagnostics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the molecular diagnostics devices and equipment market by increasing costs of imported PCR machines, sequencing instruments, reagents, enzymes, and software-enabled hardware components. Diagnostic laboratories and hospitals in North America and Europe are significantly affected due to dependence on imported high-precision equipment, while Asia-Pacific faces cost pressures on reagent exports. These tariffs are raising testing costs and slowing system upgrades. At the same time, they are supporting local manufacturing, regional reagent production, and increased innovation in cost-efficient molecular diagnostic platforms.
The molecular diagnostics devices and equipment market research report is one of a series of new reports that provides molecular diagnostics devices and equipment market statistics, including molecular diagnostics devices and equipment industry global market size, regional shares, competitors with a molecular diagnostics devices and equipment market share, detailed molecular diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics devices and equipment industry. This molecular diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Molecular diagnostics devices are utilized for the diagnosis of infectious diseases and screening by detecting specific sequences in DNA or RNA. These devices aid in providing more accurate therapeutic interventions, especially in the early stages of a disease.
The main products of molecular diagnostics devices include instruments, reagents, and consumables. Reagents, in this context, refer to substances used to cause a chemical reaction, often employed to indicate the presence of another substance. Various technologies are involved in molecular diagnostics, such as DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription-mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others such as southern blotting, northern blotting, and electrophoresis. These technologies find applications in cancer diagnosis, pharmacogenomics, genetic testing, infectious disease detection, prenatal screening, neurological disease analysis, and cardiovascular disease assessment. Molecular diagnostics devices are used by various end-users, including diagnostic laboratories, hospitals, and others such as nursing homes, blood banks, and point-of-care facilities.
The molecular diagnostics devices and equipment market consist of sales of thermocycler, single particle mass spectrometers, time-of-flight mass spectrometer (TOF) and others that are used to detect pathogen and infectious diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. This market is segmented into instruments, reagents, and consumables.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The molecular diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising investments in genomic diagnostics, expansion of decentralized molecular testing, growing adoption of automated sample processing, increasing focus on early-stage disease detection. Major trends in the forecast period include increasing adoption of pcr-based testing platforms, rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, expansion of companion diagnostics applications, enhanced focus on early and personalized diagnosis.
The increasing incidence of infectious diseases is expected to drive the growth of the molecular diagnostic devices and equipment market in the future. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals or from animals to humans. Factors contributing to the rise in infectious diseases include antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic devices and equipment are critical tools for the detection and management of these diseases. For example, in March 2023, the Office for National Statistics, a UK government department, reported that during the week ending March 17, 2023, the UK recorded 619 deaths related to COVID-19, an increase from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, a slight decrease from 4.6% the week before. Thus, the rising incidence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.
Major companies in the molecular diagnostics devices and equipment market are innovating by developing products such as high-throughput sample-to-result instruments for molecular diagnostics. ELITechGroup, for instance, launched a high-throughput sample-to-result instrument in April 2023, based on its proven extraction and assay technology. The instrument allows continuous loading of samples and reagents with real random-access capability, providing users with the flexibility to run different PCR reagents, protocols, and sample matrices in parallel.
In February 2023, Sherlock Biosciences, a US-based synthetic biology firm, acquired Sense Bio-detection for an undisclosed sum. With this acquisition, Sherlock intends to enhance its CRISPR-based molecular diagnostics capabilities by incorporating Sense Bio-detection’s Veros instrument-free rapid test platform and manufacturing expertise. Sense Bio-detection is a UK-based molecular diagnostics company offering single-use molecular testing devices.
Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular diagnostics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the molecular diagnostics devices and equipment market by increasing costs of imported PCR machines, sequencing instruments, reagents, enzymes, and software-enabled hardware components. Diagnostic laboratories and hospitals in North America and Europe are significantly affected due to dependence on imported high-precision equipment, while Asia-Pacific faces cost pressures on reagent exports. These tariffs are raising testing costs and slowing system upgrades. At the same time, they are supporting local manufacturing, regional reagent production, and increased innovation in cost-efficient molecular diagnostic platforms.
The molecular diagnostics devices and equipment market research report is one of a series of new reports that provides molecular diagnostics devices and equipment market statistics, including molecular diagnostics devices and equipment industry global market size, regional shares, competitors with a molecular diagnostics devices and equipment market share, detailed molecular diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics devices and equipment industry. This molecular diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Molecular diagnostics devices are utilized for the diagnosis of infectious diseases and screening by detecting specific sequences in DNA or RNA. These devices aid in providing more accurate therapeutic interventions, especially in the early stages of a disease.
The main products of molecular diagnostics devices include instruments, reagents, and consumables. Reagents, in this context, refer to substances used to cause a chemical reaction, often employed to indicate the presence of another substance. Various technologies are involved in molecular diagnostics, such as DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription-mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others such as southern blotting, northern blotting, and electrophoresis. These technologies find applications in cancer diagnosis, pharmacogenomics, genetic testing, infectious disease detection, prenatal screening, neurological disease analysis, and cardiovascular disease assessment. Molecular diagnostics devices are used by various end-users, including diagnostic laboratories, hospitals, and others such as nursing homes, blood banks, and point-of-care facilities.
The molecular diagnostics devices and equipment market consist of sales of thermocycler, single particle mass spectrometers, time-of-flight mass spectrometer (TOF) and others that are used to detect pathogen and infectious diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. This market is segmented into instruments, reagents, and consumables.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Molecular Diagnostics Devices and Equipment Market Characteristics
3. Molecular Diagnostics Devices and Equipment Market Supply Chain Analysis
4. Global Molecular Diagnostics Devices and Equipment Market Trends and Strategies
5. Molecular Diagnostics Devices and Equipment Market Analysis of End Use Industries
7. Global Molecular Diagnostics Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Molecular Diagnostics Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Molecular Diagnostics Devices and Equipment Market Segmentation
10. Molecular Diagnostics Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Molecular Diagnostics Devices and Equipment Market
12. China Molecular Diagnostics Devices and Equipment Market
13. India Molecular Diagnostics Devices and Equipment Market
14. Japan Molecular Diagnostics Devices and Equipment Market
15. Australia Molecular Diagnostics Devices and Equipment Market
16. Indonesia Molecular Diagnostics Devices and Equipment Market
17. South Korea Molecular Diagnostics Devices and Equipment Market
18. Taiwan Molecular Diagnostics Devices and Equipment Market
19. South East Asia Molecular Diagnostics Devices and Equipment Market
20. Western Europe Molecular Diagnostics Devices and Equipment Market
21. UK Molecular Diagnostics Devices and Equipment Market
22. Germany Molecular Diagnostics Devices and Equipment Market
23. France Molecular Diagnostics Devices and Equipment Market
24. Italy Molecular Diagnostics Devices and Equipment Market
25. Spain Molecular Diagnostics Devices and Equipment Market
26. Eastern Europe Molecular Diagnostics Devices and Equipment Market
27. Russia Molecular Diagnostics Devices and Equipment Market
28. North America Molecular Diagnostics Devices and Equipment Market
29. USA Molecular Diagnostics Devices and Equipment Market
30. Canada Molecular Diagnostics Devices and Equipment Market
31. South America Molecular Diagnostics Devices and Equipment Market
32. Brazil Molecular Diagnostics Devices and Equipment Market
33. Middle East Molecular Diagnostics Devices and Equipment Market
34. Africa Molecular Diagnostics Devices and Equipment Market
36. Molecular Diagnostics Devices and Equipment Market Competitive Landscape and Company Profiles
37. Molecular Diagnostics Devices and Equipment Market Other Major and Innovative Companies
40. Molecular Diagnostics Devices and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Molecular Diagnostics Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses molecular diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for molecular diagnostics devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular diagnostics devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Reagents And Consumables; Software2) By Technology: DNA(Deoxyribonucleic acid) sequencing; Polymerase chain reaction; Isothermal Nucleic Acid Amplification Technology; Transcription Mediated Amplification (TMA); In situ hybridization; Microarrays; Mass spectrometry; Other Technologies
3) By Application: Cancer; Pharmacogenomics; Genetic testing; Infectious disease; Prenatal; Other Applications
4) By End User: Diagnostic laboratories; Hospitals; Other End Users
Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines; Nucleic Acid Analyzers; DNA Sequencers; Microarrays2) By Reagents And Consumables: PCR Reagents; DNA Probes And Primers; Sample Preparation Kits; Control And Calibration Materials
3) By Software: Data Analysis Software; Laboratory Information Management Systems (LIMS); Bioinformatics Software; Integration Software For Instrumentation
Companies Mentioned: F. Hoffmann-La Roche Ltd; QIAGEN N.V.; Abbott Laboratories; Danaher Corporation; Biomérieux; Becton Dickinson & Co; Siemens Healthineers AG; Grifols S.A.; Sysmex Corporation; Abbott India Limited; Qiagen India Pvt Ltd; Biocartis; Bio-Techne India Private Limited; Cleaver Scientific; Zhejiang Di'an Diagnostics Technology Co. Ltd; Kindstar Global; BGI-Shenzhen; OriGene Technologies; Nippon Becton Dickinson Company; QuantuMDx; Yourgene Health; Genefirst; TestLine; Hologic Inc.; Illumina Inc.; Cepheid Inc.; Agilent Technologies Inc.; AutoGenomics; Bio-Rad Laboratories Inc; Ortho Clinical Diagnostics Inc; Sysmex Middle East FZ-LLC; QIAGEN SA (Pty) Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Molecular Diagnostics Devices and Equipment market report include:- F. Hoffmann-La Roche Ltd
- QIAGEN N.V.
- Abbott Laboratories
- Danaher Corporation
- Biomérieux
- Becton Dickinson & Co
- Siemens Healthineers AG
- Grifols S.A.
- Sysmex Corporation
- Abbott India Limited
- Qiagen India Pvt Ltd
- Biocartis
- Bio-Techne India Private Limited
- Cleaver Scientific
- Zhejiang Di'an Diagnostics Technology Co. Ltd
- Kindstar Global
- BGI-Shenzhen
- OriGene Technologies
- Nippon Becton Dickinson Company
- QuantuMDx
- Yourgene Health
- Genefirst
- TestLine
- Hologic Inc.
- Illumina Inc.
- Cepheid Inc.
- Agilent Technologies Inc.
- AutoGenomics
- Bio-Rad Laboratories Inc
- Ortho Clinical Diagnostics Inc
- Sysmex Middle East FZ-LLC
- QIAGEN SA (Pty) Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 30.33 Billion |
| Forecasted Market Value ( USD | $ 48.84 Billion |
| Compound Annual Growth Rate | 12.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
